IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 244 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.51 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $13,928,000 | -12.8% | 836,518 | 0.0% | 0.74% | -2.8% |
| Q4 2021 | $15,969,000 | -22.6% | 836,518 | 0.0% | 0.76% | -29.1% |
| Q3 2021 | $20,629,000 | +17.4% | 836,518 | +23.9% | 1.07% | +37.0% |
| Q2 2021 | $17,568,000 | +20.2% | 675,160 | +46.2% | 0.78% | +29.0% |
| Q1 2021 | $14,621,000 | -18.0% | 461,811 | +20.2% | 0.60% | -20.9% |
| Q4 2020 | $17,823,000 | +40.6% | 384,117 | -0.2% | 0.76% | +21.5% |
| Q3 2020 | $12,672,000 | – | 384,938 | – | 0.63% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 12,201,261 | $203,150,000 | 4.07% |
| Paradigm Biocapital Advisors LP | 907,428 | $15,109,000 | 4.00% |
| Avoro Capital Advisors LLC | 9,125,000 | $151,931,000 | 2.77% |
| Logos Global Management LP | 1,000,000 | $16,650,000 | 2.16% |
| Avidity Partners Management LP | 6,043,219 | $100,620,000 | 2.10% |
| Orbimed Advisors | 6,633,006 | $110,440,000 | 1.79% |
| Parametrica Management Ltd | 134,679 | $2,240,000 | 1.66% |
| Boxer Capital, LLC | 1,935,133 | $32,220,000 | 1.66% |
| Fairmount Funds Management LLC | 389,588 | $6,487,000 | 1.53% |
| Long Focus Capital Management, LLC | 705,000 | $11,738,000 | 1.51% |